Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Longxin Pharmaceutical is a China-based pharmaceutical company headquartered in Foshan, Guangdong Province. The company specializes in the research, development, manufacturing, and commercialization of chemical drug products, with a strong focus on finished dosage forms and active pharmaceutical ingredients (APIs). Its product portfolio spans several therapeutic areas, including cardiovascular health, gastroenterology, and anti-infectives. Longxin Pharmaceutical operates modern manufacturing facilities that comply with Good Manufacturing Practice (GMP) standards to ensure high-quality production for domestic and international markets. The firm is particularly active in the consistency evaluation of generic drugs, aiming to provide affordable and high-quality therapeutic options. Through its integrated R&D and production capabilities, the company continues to expand its presence in the Chinese healthcare sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 广东隆信制药.